Literature DB >> 3131146

Clinical criteria for the diagnosis of vascular dementia.

C Loeb1.   

Abstract

The clinical diagnosis of dementia includes medical history, neurological examination, psychiatric interview and dementia scale. The identification of conditions producing dementia can only be achieved by adding to the clinical information the data gathered from ancillary investigations. The usual ancillary diagnostic investigations (biochemical tests, cerebrospinal fluid (CSF), EEG, CT, MRI, angiography) can rather easily identify brain disorders due to tumors, vascular malformations, hematomas, infections, toxins and drugs, deficiency diseases, normal-pressure hydrocephalus, metabolic and endocrine derangements. The differential diagnosis between degenerative and vascular dementia needs laboratory tests such as CSF, EEG, Somatosensory Evoked Potentials, CT (which constitutes a major role in a modified ischemic score) and MRI. The three final diagnostic labels are possible, probable and definite vascular dementia, which include clinical features and laboratory investigations concurrently confirming the diagnosis. If ancillary investigations fail to show multiple infarct lesions or if mixed forms are suspected an unequivocal diagnosis can be made only on histopathological evidence.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3131146     DOI: 10.1159/000116237

Source DB:  PubMed          Journal:  Eur Neurol        ISSN: 0014-3022            Impact factor:   1.710


  7 in total

1.  Decreased cerebral glucose metabolism associated with mental deterioration in multi-infarct dementia.

Authors:  K Meguro; C Doi; M Ueda; T Yamaguchi; H Matsui; S Kinomura; M Itoh; K Yamada; H Sasaki
Journal:  Neuroradiology       Date:  1991       Impact factor: 2.804

Review 2.  Clinical evaluation of the ICD-10 criteria for vascular dementia.

Authors:  T Wetterling; R D Kanitz; K J Borgis
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1993       Impact factor: 5.270

3.  A multi-institutional study of interobserver agreement in the evaluation of dementia with rCBF/SPET technetium-99m exametazime (HMPAO).

Authors:  R S Hellman; R S Tikofsky; R Van Heertum; G Coade; R Carretta; R G Hoffmann
Journal:  Eur J Nucl Med       Date:  1994-04

Review 4.  Vascular dementia: Cognitive, functional and behavioral assessment. Recommendations of the Scientific Department of Cognitive Neurology and Aging of the Brazilian Academy of Neurology. Part II.

Authors:  Eliasz Engelhardt; Carla Tocquer; Charles André; Denise Madeira Moreira; Ivan Hideyo Okamoto; José Luiz de Sá Cavalcanti
Journal:  Dement Neuropsychol       Date:  2011 Oct-Dec

5.  Vascular Cognitive Impairment (VCI) after non-embolic ischemic stroke during a 12-month follow-up in Brazil.

Authors:  Sonia Maria Dozzi Brucki; Michel Ferreira Machado; Maria Sheila Guimarães Rocha
Journal:  Dement Neuropsychol       Date:  2012 Jul-Sep

Review 6.  Vascular dementia: Diagnostic criteria and supplementary exams. Recommendations of the Scientific Department of Cognitive Neurology and Aging of the Brazilian Academy of Neurology. Part I.

Authors:  Eliasz Engelhardt; Carla Tocquer; Charles André; Denise Madeira Moreira; Ivan Hideyo Okamoto; José Luiz de Sá Cavalcanti
Journal:  Dement Neuropsychol       Date:  2011 Oct-Dec

7.  Habituation of Somatosensory Evoked Potentials in Patients with Alzheimer's Disease and Those with Vascular Dementia.

Authors:  Antonio Currà; Lucio Marinelli; Filippo Cotellessa; Laura Mori; Chiara Avanti; Daniela Greco; Manuela Gorini; Paolo Missori; Francesco Fattapposta; Carlo Trompetto
Journal:  Medicina (Kaunas)       Date:  2021-12-14       Impact factor: 2.430

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.